Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency: an update
Authors:
- 23 November 2015
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 174 (4) , 753-762
Abstract
Neutrophilic panniculitis associated with alpha‐1‐antitrypsin deficiency (AATD) is a very rare disease. Its estimated prevalence is 1 in 1000 subjects with severe AATD (usually white individuals with a Pi*ZZ genotype). It is manifested clinically by painful recurrent ulcerating subcutaneous nodules, and characterized histologically by dense infiltrates of neutrophils in the deep dermis and connective‐tissue septae, with secondary lobular panniculitis. It may be the only clinical manifestation of AATD, although it can also occur together with the classical pulmonary or hepatic manifestations of the disease. AATD‐associated panniculitis is not only very rare but may also be significantly underdiagnosed. The physician managing a case of panniculitis with a clinical presentation suggestive of AATD and a compatible skin biopsy should measure serum AAT concentration and, if low, determine the AAT phenotype by isoelectric focusing. If uncertainty remains, the SERPINA1 gene should be sequenced to identify the genotype. If AATD is diagnosed, AATD testing of first‐degree family members should be performed in order to take appropriate preventive and therapeutic measures, including genetic counselling, education on inheritance, risk arising from tobacco smoke, occupational exposure to pollutants and hepatotoxic substances, and the provision of information on clinical management. Cases of panniculitis in which conventional therapy with dapsone has failed may be managed with intravenous augmentative therapy using human AAT. The current manuscript addresses the fundamental concepts of the pathogenesis of AATD‐associated panniculitis and describes the clinical presentation and management of cases in order to reduce underdiagnosis and improve outcomes.Keywords
This publication has 79 references indexed in Scilit:
- Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantationProceedings of the National Academy of Sciences, 2011
- Inhibition of IL-32 activation by α-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation modelBlood, 2011
- Severe ulcerative panniculitis caused by alpha 1-antitrypsin deficiency: Remission induced and maintained with intravenous alpha 1-antitrypsinJournal of the American Academy of Dermatology, 2011
- Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse modelJournal of Translational Medicine, 2011
- Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysemaOrphanet Journal of Rare Diseases, 2011
- α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8Journal of Clinical Investigation, 2010
- New Findings in PiZZ α1-Antitrypsin Deficiency-Related PanniculitisDermatology, 2009
- α-1-Antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole bloodJournal of Leukocyte Biology, 2009
- Curative and β cell regenerative effects of α1-antitrypsin treatment in autoimmune diabetic NOD miceProceedings of the National Academy of Sciences, 2008
- α1-Antitrypsin deficiency associated with panniculitisJournal of the American Academy of Dermatology, 1988